Plain-English translation of NCT04938986 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After surgery for colorectal cancer, doctors need better ways to figure out which patients might need extra treatment to prevent the cancer from coming back. This study is testing a new tool called Immunoscore®, which analyzes a sample of your tumor to predict your personal risk of recurrence. The goal is to see if this test can help doctors make better treatment decisions tailored just for you.
Right now, doctors use standard staging systems to decide who needs chemotherapy after colorectal cancer surgery, but these methods don't work perfectly for everyone. This study exists to see whether the new Immunoscore® test can give doctors more personalized information about your individual risk, so they can recommend the right level of treatment — no more, no less.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will use a sample of tumor tissue that was already removed during your cancer surgery to perform the Immunoscore® test. Your doctors will compare the results of this new test with standard treatment guidelines to see how it might change your care recommendations. You will be followed to see how well this new test predicts whether your cancer comes back.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France
Sponsor
Hospital St. Joseph, Marseille, France
Enrollment target
~100 participants
Started
April 2022
Primary completion
April 2028
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in April 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cécile BIELMANN
Hopital Saint Joseph Marseille
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.